Showing entries for:
METAvivor Research and Support announces six additional new grant awards for metastatic breast cancer research totaling $750,000. METAvivor was one of only a couple of organizations who held a full research cycle for metastatic breast cancer in 2020. As a result of strong support from generous donors and sponsors for metastatic breast cancer research, METAvivor was able to award additional grants. The grants hold promise for future treatments and therapies that will one day, change metastatic breast cancer from a terminal disease to one that is chronic yet manageable.
